AC Immune SA (ACIU) Financial Statements & Analysis

AC Immune SA (ACIU) Income Statement

AC Immune SA reported revenue of CHF 3.57M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 86.9% from CHF 27.31M a year earlier. AC Immune SA posted a net loss of CHF 70.45M, compared with a net loss of CHF 50.92M a year earlier. Gross margin was 100.0% and operating margin -1927.3%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was CHF 15.11M, up 1057.2% from the same quarter a year earlier.

AC Immune SA Income Statement Analysis

Values in millions CHF

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

AC Immune SA income statement - Annual data in millions CHF
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	3.57	27.31	14.80	3.94	0.00	15.43	110.46	7.19	20.26
Cost of Revenue	56.44	62.57	54.61	60.34	0.00	59.49	50.43	44.28	32.66
Gross Profit	3.57	-35.26	-39.81	3.94	0.00	-44.06	60.02	-37.08	-12.41
Operating Expenses
Research & Development	56.44	62.57	54.61	60.34	62.28	59.49	50.43	44.28	32.66
Selling, General & Administrative	11.65	11.43	10.58	15.79	10.88	18.56	16.06	7.56	6.27
Operating Expenses	72.44	79.69	68.43	77.47	79.01	17.20	15.49	56.74	42.79
Operating Income	-68.86	-52.38	-53.62	-73.53	-79.01	-61.26	44.54	-49.55	-22.54
Other Income/Expense
Interest Income	1.87	3.20	1.04	0.07	6.49	0.08	0.30	0.13	0.33
Interest Expense	0.19	0.13	0.18	-0.36	0.58	-0.18	1.93	0.33	0.15
Other Income/Expense	-3.26	-1.60	-1.47	-0.18	6.02	-0.66	0.91	-1.40	-3.87
Income
Income Before Tax	-70.45	-50.91	-54.22	-70.74	-72.99	-61.92	45.44	-50.95	-26.41
Income Tax Expense	0.00	0.00	0.01	0.01	0.00	0.00	0.00	0.00	0.15
Net Income	-70.45	-50.92	-54.23	-70.75	-73.00	-61.92	45.44	-50.95	-26.41
Net Income - Continuous Operations	-70.45	-50.92	-54.23	-70.75	-73.00	-61.92	45.44	-50.95	-26.41
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	-67.75	-48.62	-51.83	-69.05	-70.01	-59.73	45.81	-49.66	-22.54
EBIT	-70.26	-50.78	-54.05	-70.85	-72.41	-61.26	-	-	-
Depreciation & Amortization	1.62	1.15	1.07	1.79	2.41	1.54	1.27	0.96	0.58
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	1.00	-1.00	-
Diluted EPS	-1.00	-1.00	-1.00	-1.00	-1.00	-1.00	1.00	-1.00	-
Basic Shares Outstanding	100.75	99.84	84.69	83.55	74.95	71.90	70.60	61.84	57.08
Diluted Shares Outstanding	100.75	99.84	84.69	83.55	74.95	71.90	71.10	61.84	57.36

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About AC Immune SA Financial Statements

What was AC Immune SA's revenue in fiscal 2025?

AC Immune SA reported revenue of CHF 3.57M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 86.9% from CHF 27.31M a year earlier.

Is AC Immune SA profitable?

No. AC Immune SA reported a net loss of CHF 70.45M in fiscal 2025. In fiscal 2024 it lost CHF 50.92M.

What is AC Immune SA's operating margin?

AC Immune SA's operating income was −CHF 68.86M on revenue of CHF 3.57M in fiscal 2025, an operating margin of -1927.3%, compared with -191.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition